2.4.0.8125 - Disclosure - STOCK-BASED COMPENSATION (Details 3)truefalsefalse1false USDfalsefalseP01_01_2013To06_30_2013http://www.sec.gov/CIK0001333763duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$1true 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Options outstanding under the plan:2false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse75617097561709falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Total options outstanding3false 5us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse006 years 2 months 26 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Weighted average remaining contractual life (in years)4false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3.583.58USD$falsetruefalsenum:perShareItemTypedecimalThe weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average exercise price per share5false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse48989594898959falsefalsefalsexbrli:sharesItemTypesharesAs of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Total options outstanding and vested6false 5chtp_ShareBasedCompensationArrangementByShareBasedPaymentAwardInMoneyOptionsOutstandingNumberchtp_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse24898882489888falsefalsefalsexbrli:sharesItemTypesharesThe number of shares reserved for issuance under, in the money stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.No definition available.false1Total in-the-money options outstanding7false 5chtp_ShareBasedCompensationArrangementByShareBasedPaymentAwardInMoneyOptionsOutstandingIntrinsicValuechtp_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse25960182596018USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of difference between fair value of the underlying shares reserved for issuance and exercise price of in the money options outstanding.No definition available.false2Aggregate intrinsic value of in-the-money options outstanding8false 5chtp_ShareBasedCompensationArrangementByShareBasedPaymentAwardInMoneyOptionsVestedAndExpectedToVestOutstandingNumberchtp_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse757388757388falsefalsefalsexbrli:sharesItemTypesharesAs of the balance sheet date, the number of shares into which fully vested and expected to vest in the money stock options outstanding can be converted under the option plan.No definition available.false1Total in-the-money options vested and outstanding9false 5chtp_ShareBasedCompensationArrangementByShareBasedPaymentAwardInMoneyOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValuechtp_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse561043561043USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of difference between fair value of the underlying shares reserved for issuance and exercise prices of fully vested and expected to vest in the money options outstanding.No definition available.false2Aggregate intrinsic value of in-the-money options outstanding and vestedfalseSTOCK-BASED COMPENSATION (Details 3) (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.chelseatherapeutics.com/role/StockbasedCompensationDetails319